SIRT1 and melanoma: The dual SIRT1/SIRT3 inhibitor 4’-BR showed caspase 3-dependent apoptosis, p21-dependent cell cycle arrest, and metabolic reprogramming (decreased glucose uptake, lactate formation, and NAD+/NADH ratio) in melanoma cells [Table 4][131].